Substanzen · Cathinon-Derivate
2-CMC
- Bevorzugter Name
- 2-CMC
- IUPAC-Name
- 1-(2-chlorophenyl)-2-(methylamino)propan-1-one
- CAS-Nummer der Stammverbindung (Referenz)
- 1246911-70-5
- Summenformel
- C10H12ClNO
- Molekulargewicht
- 197.66 g/mol
- InChIKey
- UHVGPEBZWPKWNT-UHFFFAOYSA-N
- PubChem
- CID 112693018
- Quelle
- PubChem
- Geprüfte Synonyme und Katalogkürzel
-
2-Chloromethcathinone 2CMC 2 CMC 2-Chloro-N-methylcathinone
Passende Artikel im aktuellen Shop-Katalog
Geprüftes Pharmakologie- & Toxikologie-Dossier
2-CMC (2-Chloromethcathinone)
Rezeptor-Telemetrie & Wirkmechanismus
Steric hindrance from the ortho-chlorine atom dramatically alters transporter recognition compared to 3-CMC and 4-CMC. In rat brain synaptosomes (Walther et al., 2018), 2-CMC acts as a selective norepinephrine and dopamine releasing agent (NET EC50 = 93 ± 6 nM; DAT EC50 = 179 ± 22 nM) with nearly 20-fold weaker serotonin release than 4-CMC (SERT EC50 = 2,815 ± 620 nM; SERT/DAT ratio ~15.7). Consequently, 2-CMC produces catecholaminergic stimulation devoid of a heavy serotonergic 'roll'.
Biotransformation & Active Metabolites
2-Chlorocathinone (ortho-chlorocathinone) and dihydro-2-CMC are expected analytical metabolites based on methcathinone pathways; reference-standard suppliers note that specific human metabolic and toxicological studies have not yet been published.
Zeitliche Pharmakokinetik
Mild, clear-headed, functional psychostimulant profile predicted from its NDRA pharmacology—offering wakefulness, conversational alertness, and modest dopaminergic mood lift without serotonergic haziness.
- Onset 20–45 minutes oral (tentative class estimate; 5–15 minutes mucosal exposure)
- Peak Window 45–90 minutes
- Total Window 2.5–4.5 hours oral (tentative class estimate; 1.5–2.5 hours mucosal exposure)
- Residual / Half-Life 2–6 hours of residual adrenergic wakefulness; human elimination half-life and clinical toxicokinetics are unverified.
No independent human quantitative brackets trials or TripSit/PsychonautWiki tables exist for 2-CMC. Because 2-CMC is ~6.9-fold weaker at DAT than 3-CMC and largely inactive at SERT, users expecting a 4-MMC/4-CMC empathogenic surge face a major trap: escalating past ~150–180 mg cannot unlock serotonergic elevated dopaminergic tone because NET potency (EC50 = 93 nM) outpaces DAT (179 nM), driving disproportionate tachycardia, hypertension, and peripheral vasoconstriction instead.
Quantitatives Wirkungsspektrum (Literaturdaten)
Third-person observational & toxicological brackets reported in scientific and harm-reduction literature — reference telemetry only, never consumption advice.
25–40 mg (tentative SAR estimate)
Subtle mental clearing, reduced drowsiness, and slight increase in task attentiveness.
Minimal somatic sensation; faint uptick in resting pulse.
40–75 mg (tentative SAR estimate)
Crisp wakefulness, calm focus, light sociability, and mild mood elevation without perceptual distortion.
Mild appetite suppression, dry mouth, and gentle adrenergic energy.
75–130 mg (tentative SAR estimate)
Clear dopaminergic motivation, talkativeness, enhanced alertness, and social confidence with minimal empathogenic softness.
Noticeable heart-rate and blood-pressure elevation, sweating, mild jaw tension, and cool fingertips.
130–180 mg (tentative SAR estimate)
Restless, jittery stimulation, racing thoughts, hyper-vigilance, and rising adrenergic tension.
Pronounced tachycardia (NET-driven), vasoconstriction, bruxism, tremor, and post-peak insomnia.
180–250+ mg (tentative SAR estimate)
Acute anxiety, panic, irritability, working-memory disruption, and potential paranoid overstimulation.
Severe hypertension, chest tightness, palpitations, peripheral vasospasm, hyperthermia, and seizure risk.
Wechselwirkungsmatrix — Niemals kombinieren
Lebensgefahr — Niemals kombinieren
Potent norepinephrine and dopamine release (NET EC50 = 93 nM) under MAO inhibition triggers life-threatening hypertensive crisis, cerebral hemorrhage, and hyperthermia.
Synergistic noradrenergic vasoconstriction and cardiac workload risk acute arrhythmias, vasospasm, and myocardial ischemia.
Lowers seizure threshold while compounding noradrenergic hypertension and convulsion risk.
Hohes Risiko — Vermeiden
Adds heavy noradrenergic cardiovascular and thermoregulatory strain onto serotonergic entactogens.
Masks subjective sedation, leading to excessive depressant intake and cardiovascular/dehydration strain.
Vorsicht / Abschwächung
Amplifies 2-CMC's prominent NET-mediated heart-rate elevation, jitteriness, and peripheral coldness.
SNRIs can additively increase noradrenergic blood-pressure and heart-rate elevation.
Isomeren- & Strukturvergleich
Within the CMC triad, 2-CMC is by far the least potent and most catecholamine-selective isomer: it is ~6.9-fold less potent at DAT than 3-CMC (179 nM vs. 26 nM) and ~19.5-fold weaker at SERT than 4-CMC (2,815 nM vs. 144 nM). Pharmacologically, 2-CMC parallels ortho-methylated 2-MMC—acting as a clearer, non-empathogenic stimulant, though ~2.2-fold less potent at DAT than 2-MMC (81 nM).
Stabilität & Lagerung
Form: White to off-white crystalline solid or clear crystal shards as the monohydrochloride salt (recrystallized HCl mp 172–174 °C; lit. 159–161 °C). · Soluble in PBS (pH 7.2, ~5 mg/mL), ethanol (~5 mg/mL), DMF (~5 mg/mL), and DMSO (~10 mg/mL).
Subject to beta-keto reduction and instability in biological/aqueous media; store sealed, dry, and protected from light at cool temperatures.
Cross-Tolerance & Dependence Profile
Expected cross-tolerance with all dopaminergic/noradrenergic stimulants (2-MMC, 3-CMC, amphetamine), halving in ~3–7 days and returning to baseline in 1–2 weeks. Psychological repeated exposure cravings occur if chased for elevated dopaminergic tone, while long-term human toxicity remains unstudied.
Chemische Struktur und Molekülprofil
2-CMC (1-(2-chlorophenyl)-2-(methylamino)propan-1-one) ist eine Referenzverbindung aus der Stoffklasse Cathinon-Derivate mit der Summenformel C10H12ClNO und einer molaren Masse von 197.66 g/mol. Die Stammverbindung wird unter der CAS-Nummer 1246911-70-5 sowie in der NCBI-PubChem-Datenbank unter CID 112693018 geführt (Standard-InChIKey: UHVGPEBZWPKWNT-UHFFFAOYSA-N). Diese Verbindung teilt ihre Summenformel (C10H12ClNO) mit Konstitutions- oder Positionsisomeren; die eindeutige Identifizierung erfolgt über den vollständigen IUPAC-Namen und die CAS-Nummer (1246911-70-5).
Quellen
- PubChem — PubChem (2026-11-12)
Referenztoxikologie und Sicherheitsprofil
Laut dokumentierten Referenzdaten (PubChem / PsychonautWiki, CC BY 4.0) gehört 2-CMC zur chemischen Klasse Cathinon-Derivate. Als substituiertes Beta-Keton (Cathinon-Derivat) erfordert diese Verbindung eine präzise analytische Reinheitsprüfung; Kontraindikationen bestehen insbesondere mit MAO-Hemmern und Serotonergika. Beim Umgang im Labor sind geeignete persönliche Schutzausrüstung und das Sicherheitsdatenblatt (SDB) zu beachten.
Quellen
- PubChem — PubChem (2026-11-12)
Analytischer Verwendungszweck und Laborhinweis
Dieses Datenblatt dient ausschließlich der chemischen, analytischen und toxikologischen Dokumentation. Das Material ist nicht für den menschlichen Verzehr bestimmt. Ein Forschungshinweis begründet keinen Rechtsstatus.
Quellen
- Gesetze im Internet — Neue-psychoaktive-Stoffe-Gesetz (NpSG) & BtMG — Bundesministerium der Justiz (2026-11-12)